Background Schizophrenia is a common, severe, and usually chronic disorder. Maintenance
treatment with antipsychotic drugs can prevent relapse but also causes side-effects. We …

Clinical practice guidelines (CPGs) translate evidence into recommendations to improve
patient care and outcomes. To provide an overview of schizophrenia CPGs, we conducted a …

Background Evidence of comparative benefits of long-acting injectable antipsychotics (LAIs)
versus oral antipsychotics for schizophrenia has been inconsistent across study designs …

This mirror-image study aimed to evaluate the real-life effectiveness of long-acting injectable
antipsychotics (LAI) in schizophrenia. Patients with schizophrenia initiating LAIs January …

Schizophrenia is a serious mental illness that requires continuous and effective long-term
management to reduce symptoms, improve quality of life, and prevent relapse. Oral …

Importance Schizophrenia is generally considered to be among the most severe psychiatric
disorders because of the excessive mortality associated with it. Research to find means to …

Schizophrenia often requires long-term treatment with antipsychotic medication. This study
aims to measure the continuity of antipsychotic treatment over the course of illness in …

Adherence to daily oral antiretroviral therapy (ART) is a barrier to both treatment and
prevention of human immunodeficiency virus (HIV) infection. To overcome limitations of life …

Background Schizophrenia is a severe psychiatric disorder with periods of remission and
relapse. As discontinuation of antipsychotic medication is the most important reason for …

Importance Evidence for improved clinical outcomes with long-acting injectable
antipsychotics (LAIAs) vs oral antipsychotics (OAs) is limited in Asian populations and …